IQ EQ FUND MANAGEMENT IRELAND Ltd Has $6.16 Million Stake in UnitedHealth Group Incorporated $UNH

IQ EQ FUND MANAGEMENT IRELAND Ltd lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 41.1% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 19,733 shares of the healthcare conglomerate’s stock after purchasing an additional 5,748 shares during the period. IQ EQ FUND MANAGEMENT IRELAND Ltd’s holdings in UnitedHealth Group were worth $6,156,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Brighton Jones LLC raised its holdings in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after purchasing an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC raised its stake in shares of UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after buying an additional 2,324 shares during the last quarter. Avidian Wealth Enterprises LLC boosted its stake in UnitedHealth Group by 1.6% in the first quarter. Avidian Wealth Enterprises LLC now owns 2,449 shares of the healthcare conglomerate’s stock valued at $1,283,000 after acquiring an additional 39 shares during the last quarter. Amalgamated Bank lifted its stake in shares of UnitedHealth Group by 0.8% in the 1st quarter. Amalgamated Bank now owns 186,742 shares of the healthcare conglomerate’s stock valued at $97,806,000 after purchasing an additional 1,446 shares during the period. Finally, Northwest Wealth Management LLC grew its stake in shares of UnitedHealth Group by 18.4% during the first quarter. Northwest Wealth Management LLC now owns 700 shares of the healthcare conglomerate’s stock worth $367,000 after purchasing an additional 109 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on UNH shares. Morgan Stanley raised their target price on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a report on Friday, September 12th. Robert W. Baird reaffirmed an “underperform” rating and issued a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Barclays lifted their price target on shares of UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a research report on Thursday, October 9th. JPMorgan Chase & Co. lifted their target price on UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a report on Thursday, October 9th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $440.00 price target on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Eighteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average target price of $385.13.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $365.97 on Tuesday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The firm has a market cap of $331.45 billion, a price-to-earnings ratio of 15.86, a price-to-earnings-growth ratio of 2.34 and a beta of 0.47. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The stock’s 50-day moving average is $339.58 and its 200-day moving average is $334.29.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter in the previous year, the firm posted $6.80 EPS. The company’s revenue was up 12.9% on a year-over-year basis. Equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.4%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s payout ratio is presently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.